Opendata, web and dolomites

INVICTUS

IN VItro Cavitation Through UltraSound

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 INVICTUS project word cloud

Explore the words cloud of the INVICTUS project. It provides you a very rough idea of what is the project "INVICTUS" about.

bubbles    cross    invictus    brain    fluidic    ultrasound    limiting    featuring    inception    cns    pursed    size    animal    adg    times    mostly    correct    localised    compounds    desirable    avoiding    dimensional    undergo    vitro    annual    collapse    ethical    physiological    barrier    erc    layer    hardly    endothelium    local    oscillations    models    investment    vivo    time    enhancement    blood    pharmacologists    bic    channels    shear    trials    organisational    alter    substantial    nervous    biologists    rate    simplification    endothelial    healthcare    irradiation    geometry    interactions    degenerative    turnkey    enormous    exploits    reproduce    experimentation    made    realistic    market    evident    biomimetic    confirmed    originates    diseases    company    almost    extended    volume    bbb    drug    tissues    few    vascular    expensive    stress    fidelity    provides    cells    platform    reproducible    healthy    perfusion    central    consuming    appropriate    permeability    biochemical    societal    humans    disorders    clinical    savings    billion    words    proceeding    injected    actual    inability    reversible    diseased    800    tools    exerted    micro    clinicians    bloodstream    cavitation    enhanced    economical    euros    generally    device    economic   

Project "INVICTUS" data sheet

The following table provides information about the project.

Coordinator
UNIVERSITA DEGLI STUDI DI ROMA LA SAPIENZA 

Organization address
address: Piazzale Aldo Moro 5
city: ROMA
postcode: 185
website: www.uniroma1.it

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Italy [IT]
 Total cost 150˙000 €
 EC max contribution 150˙000 € (100%)
 Programme 1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC))
 Code Call ERC-2017-PoC
 Funding Scheme ERC-POC
 Starting year 2017
 Duration (year-month-day) from 2017-12-01   to  2019-05-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    UNIVERSITA DEGLI STUDI DI ROMA LA SAPIENZA IT (ROMA) coordinator 150˙000.00

Map

 Project objective

Disorders of the central nervous system (CNS) contribute almost 800 billion euros in annual European healthcare costs. New compounds, effective in animal models, hardly work in humans, mostly due to the inability to cross the Brain Blood Barrier (BBB). In these conditions cost-effective tools to alter BBB and, more generally, endothelial layer permeability is desirable before proceeding to expensive and time-consuming animal studies. INVICTUS (IN VItro Cavitation Through UltraSound) originates within the ERC-AdG project Bubbles from Inception to Collapse (BIC) and concerns the development of a biomimetic micro-fluidic platform to be made turnkey available to biologists, clinicians and pharmacologists. The integrated platform exploits endothelial layer permeability enhancement by cavitation bubbles and provides an integrated, low cost platform to develop cavitation enhanced drug delivery under well controlled and reproducible conditions. Its potential is significant, given the well known societal and economical impact of degenerative diseases and the enormous investment and the long times of pre-clinical trials, as confirmed by a leading company operating in the field. Limiting/avoiding animal experimentation has an evident ethical impact and is associated with substantial economic savings and organisational simplification. In few words, micro-bubbles injected into the bloodstream undergo volume oscillations under localised ultrasound irradiation, with local reversible permeability enhancement of the endothelium. Already pursed in in vivo animal models, this approach is extended here to a high-fidelity, in vitro biomimetic device that will bring to market new crucial features such as the three-dimensional geometry of realistic-size vascular channels featuring an actual endothelial barrier, the correct perfusion rate, the appropriate physiological shear stress exerted on the endothelial cells and the ability to reproduce biochemical interactions between different, healthy and diseased, tissues.

 Publications

year authors and title journal last update
List of publications.
2019 Giulia Silvani, Chiara Scognamiglio, Davide Caprini, Luca Marino, Mauro Chinappi, Giorgia Sinibaldi, Giovanna Peruzzi, Mohammad F. Kiani, Carlo M. Casciola
Reversible Cavitation-Induced Junctional Opening in an Artificial Endothelial Layer
published pages: , ISSN: , DOI:
Small 2020-01-16
2018 Giovanna Peruzzi, Giorgia Sinibaldi, Giulia Silvani, Giancarlo Ruocco, Carlo Massimo Casciola
Perspectives on cavitation enhanced endothelial layer permeability
published pages: 83-93, ISSN: 0927-7765, DOI: 10.1016/j.colsurfb.2018.02.027
Colloids and Surfaces B: Biointerfaces 168 2020-01-16

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "INVICTUS" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "INVICTUS" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.1.)

CHIPTRANSFORM (2018)

On-chip optical communication with transformation optics

Read More  

OAlipotherapy (2018)

Long-retention liposomic drug-delivery for intra-articular osteoarthritis therapy

Read More  

AST (2019)

Automatic System Testing

Read More